INR 35.5
(-1.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 4.09 Million INR | 0.0% |
2022 | - INR | 0.0% |
2021 | - INR | 0.0% |
2020 | - INR | 0.0% |
2019 | - INR | 0.0% |
2018 | - INR | 0.0% |
2017 | - INR | 0.0% |
2016 | - INR | 0.0% |
2015 | - INR | 0.0% |
2014 | - INR | 0.0% |
2013 | - INR | 0.0% |
2012 | - INR | 0.0% |
2011 | - INR | 0.0% |
2010 | - INR | 0.0% |
2009 | - INR | 0.0% |
2008 | - INR | -100.0% |
2007 | 275.32 Million INR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | - INR | 0.0% |
2024 Q1 | - INR | -100.0% |
2023 Q2 | - INR | 0.0% |
2023 Q1 | - INR | 0.0% |
2023 Q4 | 4.09 Million INR | 0.0% |
2023 FY | 4.09 Million INR | 0.0% |
2023 Q3 | - INR | 0.0% |
2022 Q1 | - INR | 0.0% |
2022 FY | - INR | 0.0% |
2022 Q4 | - INR | 0.0% |
2022 Q3 | - INR | 0.0% |
2022 Q2 | - INR | 0.0% |
2021 FY | - INR | 0.0% |
2021 Q2 | - INR | 0.0% |
2021 Q3 | - INR | 0.0% |
2021 Q4 | - INR | 0.0% |
2021 Q1 | - INR | 0.0% |
2020 Q4 | - INR | 0.0% |
2020 Q2 | - INR | 0.0% |
2020 FY | - INR | 0.0% |
2020 Q3 | - INR | 0.0% |
2020 Q1 | - INR | 0.0% |
2019 FY | - INR | 0.0% |
2019 Q3 | - INR | 0.0% |
2019 Q2 | - INR | 0.0% |
2019 Q4 | - INR | 0.0% |
2019 Q1 | - INR | 0.0% |
2018 FY | - INR | 0.0% |
2018 Q4 | - INR | 0.0% |
2018 Q3 | - INR | 0.0% |
2018 Q2 | - INR | 0.0% |
2018 Q1 | - INR | -100.0% |
2017 FY | - INR | 0.0% |
2017 Q1 | - INR | -100.0% |
2017 Q2 | - INR | 0.0% |
2017 Q3 | - INR | 0.0% |
2017 Q4 | 1.86 Million INR | 0.0% |
2016 Q1 | - INR | 0.0% |
2016 FY | - INR | 0.0% |
2016 Q2 | - INR | 0.0% |
2016 Q4 | 9888.00 INR | 0.0% |
2016 Q3 | - INR | 0.0% |
2015 FY | - INR | 0.0% |
2015 Q3 | - INR | 0.0% |
2015 Q2 | - INR | 0.0% |
2015 Q1 | - INR | 0.0% |
2015 Q4 | - INR | 0.0% |
2014 Q1 | - INR | 0.0% |
2014 Q4 | - INR | 0.0% |
2014 Q3 | - INR | 0.0% |
2014 Q2 | - INR | 0.0% |
2014 FY | - INR | 0.0% |
2013 Q1 | - INR | 0.0% |
2013 FY | - INR | 0.0% |
2013 Q3 | - INR | 0.0% |
2013 Q4 | - INR | 0.0% |
2013 Q2 | - INR | 0.0% |
2012 Q4 | - INR | 0.0% |
2012 Q1 | - INR | 0.0% |
2012 FY | - INR | 0.0% |
2012 Q2 | - INR | 0.0% |
2012 Q3 | - INR | 0.0% |
2011 Q3 | - INR | 0.0% |
2011 FY | - INR | 0.0% |
2011 Q2 | - INR | 0.0% |
2011 Q4 | - INR | 0.0% |
2010 FY | - INR | 0.0% |
2009 FY | - INR | 0.0% |
2008 FY | - INR | -100.0% |
2007 FY | 275.32 Million INR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
DECIPHER LABS LIMITED | 362.75 Million INR | 98.87% |
Gujarat Themis Biosyn Limited | 1.69 Billion INR | 99.759% |
Ishita Drugs and Industries Limited | 151.87 Million INR | 97.3% |
MedPlus Health Services Limited | 56.24 Billion INR | 99.993% |
ANG Lifesciences India Limited | 1.46 Billion INR | 99.719% |
Add-Shop E-Retail Limited | 2.02 Billion INR | 99.797% |
Bacil Pharma Limited | - INR | -Infinity% |
BDH Industries Limited | 858.31 Million INR | 99.522% |
Beryl Drugs Limited | 271.24 Million INR | 98.488% |
Cian Healthcare Limited | 616.95 Million INR | 99.335% |
Chemo Pharma Laboratories Limited | 18.38 Million INR | 77.696% |
Concord Drugs Limited | 449.24 Million INR | 99.087% |
Deccan Health Care Limited | 597.28 Million INR | 99.314% |
Gujarat Terce Laboratories Limited | 479.74 Million INR | 99.145% |
Hindustan Bio Sciences Limited | 10.48 Million INR | 60.913% |
Jenburkt Pharmaceuticals Limited | 1.41 Billion INR | 99.711% |
KIMIA BIOSCIENCES LIMITED | 1.04 Billion INR | 99.609% |
Kwality Pharmaceuticals Limited | 3.07 Billion INR | 99.867% |
Makers Laboratories Limited | 1.03 Billion INR | 99.605% |
Medi-Caps Limited | 265.63 Million INR | 98.457% |
Panchsheel Organics Limited | 1.05 Billion INR | 99.61% |
Parmax Pharma Limited | 154.24 Million INR | 97.342% |
Parnax Lab Limited | 1.88 Billion INR | 99.783% |
Patidar Buildcon Limited | 2.3 Million INR | -77.643% |
Phaarmasia Limited | 305.93 Million INR | 98.66% |
Vikram Thermo (India) Limited | 1.25 Billion INR | 99.673% |
Sanjivani Paranteral Limited. | 536.87 Million INR | 99.236% |
SHAMROCK INDUSTRIAL CO.LTD. | 1.11 Million INR | -266.726% |
Smruthi Organics Limited | 1.27 Billion INR | 99.679% |
Source Natural Foods and Herbal Supplements Limited | 272.96 Million INR | 98.498% |
SUDARSHAN PHARMA INDUSTRIES LI | 4.63 Billion INR | 99.912% |
Trident Lifeline Limited | 446.28 Million INR | 99.081% |
Trinity League India Limited | 2.95 Million INR | -38.983% |
Tyche Industries Limited | 696.83 Million INR | 99.412% |
Vista Pharmaceuticals Limited | 102.87 Million INR | 96.015% |
Vivanza Biosciences Limited | 278.89 Million INR | 98.53% |
PRAVEG LIMITED | 915.96 Million INR | 99.552% |
Sastasundar Ventures Limited | 13.56 Billion INR | 99.97% |
Sunil Healthcare Limited | 901.91 Million INR | 99.545% |
Syschem (India) Limited | 2.33 Billion INR | 99.824% |
Zenith Healthcare Limited | 144.71 Million INR | 97.167% |
Zenlabs Ethica Limited | 585.63 Million INR | 99.3% |
Mercury Laboratories Limited | 755.59 Million INR | 99.457% |
SHELTER PHARMA LIMITED | 400.22 Million INR | 98.976% |
Vasundhara Rasayans Limited | 370.18 Million INR | 98.892% |
Bharat Immunologicals & Biologicals Corporation Limited | 446.09 Million INR | 99.081% |
Roopa Industries Limited | 715.53 Million INR | 99.427% |
PANJON LTD. | 125.52 Million INR | 96.734% |
Pharmaids Pharmaceuticals Limited | 151.12 Million INR | 97.287% |
TIAAN CONSUMER LIMITED | - INR | -Infinity% |
Anuh Pharma Limited | 6.47 Billion INR | 99.937% |
Crestchem Limited | 212.56 Million INR | 98.071% |
Emmessar Biotech & Nutrition Limited | 5.55 Million INR | 26.153% |
Sandu Pharmaceuticals Limited | 672.8 Million INR | 99.391% |
Fredun Pharmaceuticals Limited | 3.48 Billion INR | 99.882% |
Trimurthi Limited | 42.23 Million INR | 90.293% |
Shukra Pharmaceuticals Limited | 745.72 Million INR | 99.45% |
Norris Medicines Limited | 56.35 Million INR | 92.725% |
Veerhealth Care Limited | 142.13 Million INR | 97.115% |
Lactose (India) Limited | 1.13 Billion INR | 99.64% |
OXYGENTA PHARMACEUTICAL LIMITE | 396.42 Million INR | 98.966% |
Ambalal Sarabhai Enterprises Limited | 1.74 Billion INR | 99.765% |
Gennex Laboratories Limited | 867.14 Million INR | 99.527% |
Denis Chem Lab Limited | 1.67 Billion INR | 99.756% |
Colinz Laboratories Limited | 70.29 Million INR | 94.168% |
Godavari Drugs Limited | 1.56 Billion INR | 99.738% |
Zenotech Laboratories Limited | 368.08 Million INR | 98.886% |
Shree Ganesh Remedies Limited | 1.25 Billion INR | 99.674% |
Bharat Parenterals Limited | 2.59 Billion INR | 99.842% |
Coral Laboratories Limited | 836.6 Million INR | 99.51% |
Evoq Remedies Limited | 63.09 Million INR | 93.501% |
Kerala Ayurveda Limited | 1.02 Billion INR | 99.599% |
KOBO BIOTECH LIMITED | - INR | -Infinity% |
Natural Capsules Limited | 1.55 Billion INR | 99.736% |
Auro Laboratories Limited | 526.99 Million INR | 99.222% |